Abiopharma

Additional proxy materials for the meeting to be held on June 25, 2026

Knight-Swift Transportation Holdings Inc. Announces Pricing of Upsized $1.3 Billion Offering of Convertible Senior Notes

Philips delivers strong order intake, comparable sales growth and margin expansion in Q1; 2026 outlook reiterated

Innate Pharma - Innate Pharma Announces Conference Call and Webcast for Q1 2026 Business Update

Ceased to be an interested party - Yael Almog Almog

Equinor to commence second tranche of the 2026 share buy-back programme

Equinor vil starte andre transje av tilbakekjøpsprogrammet for aksjer for 2026

Equinor ASA: Nøkkelinformasjon angående kontantutbytte for første kvartal 2026

Equinor ASA: Key information relating to cash dividend for first quarter 2026

Equinor first quarter 2026 results